(89Zr Panitumumab) With PET/CT for Diagnosing Metastases in Patients With Head and Neck Squamous Cell Carcinoma

NCT05747625 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Squamous Cell Carcinoma
Metastatic Head and Neck Squamous Cell Carcinoma
Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck

Interventions

BIOLOGICAL: Panitumumab
DRUG: Zirconium Zr 89 Panitumumab
PROCEDURE: Positron Emission Tomography
PROCEDURE: Computed Tomography
OTHER: Electronic Health Record Review

Sponsor

Eben Rosenthal

Collaborators

[object Object]
[object Object]